Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

NCT06540963

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View Trial Details
Recruiting

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

NCT05057702

Conditions
Ependymoma, Ependymoma Malignant, Ependymoma of Brain, +12 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View Trial Details
Recruiting

Neuroblastoma Biology Study

NCT01587300

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucille Salter Packer Children's Hospital, Stanford University Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

NCT01804634

Conditions
Hepatoblastoma, Myosarcoma, Neoplasms, +19 more
Locations
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Albert Einstein College of Medicine, Children's Hospital at Montefiore The Bronx, New York, United States
  • New York Medical Center/ Maria Fareri Children's Hospital Valhalla, New York, United States
View Trial Details
Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

NCT03126916

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 162 locations
View Trial Details

Related conditions